veliparib
Showing 1 - 25 of 62
Solid Tumors With Documented BRCA, BARD, or PALB or Other Acceptable DNA Mutations or Anomalies That Are Scientifically Sound,
No longer available
- Solid Tumors With Documented BRCA, BARD, or PALB or Other Acceptable DNA Mutations or Anomalies That Are Scientifically Sound
- +3 more
- Veliparib
- (no location specified)
May 20, 2022
Malignant Solid Tumor Trial in United States (drug, other, procedure)
Active, not recruiting
- Malignant Solid Neoplasm
- Ferumoxytol
- +4 more
-
Baltimore, Maryland
- +5 more
Nov 8, 2022
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid
Active, not recruiting
- Acute Myeloid Leukemia
- +9 more
- Carboplatin
- +3 more
-
Los Angeles, California
- +5 more
Jan 27, 2023
Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma Trial in
Active, not recruiting
- Locally Advanced Pancreatic Adenocarcinoma
- +4 more
- Biopsy
- +4 more
-
Chicago, Illinois
- +11 more
Jun 28, 2022
Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, Solid Tumor Trial in New Brunswick
Active, not recruiting
- Ann Arbor Stage III Non-Hodgkin Lymphoma
- +2 more
- Cyclophosphamide
- +4 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Jan 28, 2023
Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic Mutation, Triple-Negative Breast Cancer Trial in Seattle (Veliparib,
No longer available
- Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic Mutation
- Triple-Negative Breast Cancer
- Veliparib
- +2 more
-
Seattle, WashingtonSeattle Cancer Care Allliance
Jul 14, 2021
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +15 more
- Laboratory Biomarker Analysis
- +3 more
-
Chicago, Illinois
- +2 more
Jan 12, 2023
Metastatic Malignant Solid Tumor, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma Trial in United States
Active, not recruiting
- Metastatic Malignant Solid Neoplasm
- +4 more
- Laboratory Biomarker Analysis
- +4 more
-
Phoenix, Arizona
- +14 more
Sep 1, 2022
Testicular Cancer Trial in Bratislava (Veliparib, Gemcitabine, Carboplatin)
Completed
- Testicular Cancer
- Veliparib
- +2 more
-
Bratislava, SlovakiaNational Cancer Institute
Mar 2, 2021
Small Cell Lung Cancer SCLC Trial in München Gauting (veliparib, Topotecan)
Recruiting
- Small Cell Lung Cancer SCLC
- veliparib
- Topotecan
-
München Gauting, GermanyKlinik München Gauting
Jan 26, 2021
Gastric Cancer Trial in Korea, Republic of, United States (Veliparib)
Completed
- Gastric Cancer
- Veliparib
-
Scottsdale, Arizona
- +7 more
Jul 29, 2021
Advanced Solid Tumor, Aggressive Non-Hodgkin Lymphoma, Recurrent Solid Tumor Trial in Chicago (other, biological, drug)
Unknown status
- Advanced Solid Neoplasm
- +5 more
- Laboratory Biomarker Analysis
- +3 more
-
Chicago, IllinoisNorthwestern University
Oct 27, 2020
Pancreatic Cancer Trial in Los Angeles (Veliparib, Gemcitabine, Intensity modulated radiation therapy)
Completed
- Pancreatic Cancer
- Veliparib
- +2 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Jul 13, 2020
Advanced Malignant Solid Tumor Trial in United States (Adavosertib, Carboplatin, Everolimus)
Completed
- Advanced Malignant Solid Neoplasm
- Adavosertib
- +5 more
-
Aurora, Colorado
- +7 more
Apr 11, 2022
NSCLC Stage III Trial in United States (Paclitaxel, Placebo for Veliparib, Carboplatin)
Terminated
- Non-small Cell Lung Cancer Stage III
- Paclitaxel
- +4 more
-
La Jolla, California
- +11 more
Jul 8, 2020
Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)
Active, not recruiting
- Anaplastic Astrocytoma
- +2 more
- Radiation Therapy
- +2 more
-
Birmingham, Alabama
- +162 more
Dec 30, 2022
Castration-Resistant Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer AJCC v7 Trial in United States
Completed
- Castration-Resistant Prostate Carcinoma
- +2 more
- Abiraterone Acetate
- +3 more
-
Duarte, California
- +13 more
Oct 21, 2020
Stage IV Fallopian Tube Cancer AJCC v6 and v7, Stage IV Ovarian Cancer AJCC v6 and v7, Stage IV Primary Peritoneal Cancer AJCC
Completed
- Stage IV Fallopian Tube Cancer AJCC v6 and v7
- +2 more
- Floxuridine
- +3 more
-
Scottsdale, Arizona
- +4 more
Jul 1, 2020
Metastatic Breast Cancer Trial in Worldwide (Placebo, Veliparib, Carboplatin)
Completed
- Metastatic Breast Cancer
- Placebo
- +4 more
-
Birmingham, Alabama
- +119 more
Sep 27, 2021
Fallopian Tube Carcinoma, Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma Trial in United States
Completed
- Fallopian Tube Carcinoma
- +37 more
- Bevacizumab
- +5 more
-
Birmingham, Alabama
- +22 more
Oct 19, 2021
Metastatic BRCA-Associated Breast Carcinoma, Metastatic Breast Carcinoma, Metastatic Malignant Tumor in the Brain Trial in
Active, not recruiting
- Metastatic BRCA-Associated Breast Carcinoma
- +5 more
- Cisplatin
- +3 more
-
Anchorage, Alaska
- +815 more
Aug 5, 2022
Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v7, Stage III Rectal Cancer AJCC v7 Trial in Puerto Rico, United States
Active, not recruiting
- Rectal Adenocarcinoma
- +2 more
- Capecitabine
- +6 more
-
Birmingham, Alabama
- +649 more
Aug 5, 2022
Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer Trial in
Completed
- Estrogen Receptor-negative Breast Cancer
- +7 more
- Paclitaxel
- +4 more
-
Bethesda, Maryland
- +2 more
Oct 7, 2019
Cancer Trial (Veliparib)
Withdrawn
- Cancer
- Veliparib
- (no location specified)
Jul 1, 2019